The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Targeting Protein Serine/Threonine Phosphatases for Drug Development
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116 · cited 3×
“, cyclosporin A, FK506, cantharidin, and fostriecin) specifically bind and inhibit serine/threonine phosphatase catalytic subunits (Liu et al., 1991; Li and Casida, 1992; Honkanen, 1993; Walsh et al., 1997).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 1×
“Because dysregulation of IKK activity has been implicated in several human pathologies, including immune and inflammatory diseases (Courtois and Gilmore, 2006; Karin, 2006), it is not surprising that the IKK complex has become an increasingly popular drug target.”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344 · cited 3×
“Spontaneous mutations in both and isoforms of the A subunit occur at low frequency in several human cancers (e.g., cervical, lung, breast, and colon) (Ruediger et al., 2001a; Arroyo and Hahn, 2005; Cho and Xu, 2007; Westermarck and Hahn, 2008).”
BackgroundIdentification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325
Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D., & Morrison, D. K. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00535-9 · Cited by 296 · cited 4×
“Recent studies have revealed that two members of the PPP family of phosphatases, PP2A and PP5, associate with Raf1 and function as positive (PP2A) and negative (PP5) modulators of Raf1 activation by dephosphorylating the inhibitory and activating phosphosites, respectively (Abraham et al., 2000; Ory et al., 2003; Adam…”
BackgroundInfluentialActions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits
Silverstein, A. M., Barrow, C. A., Davis, A. J., & Mumby, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072071699 · Cited by 276
Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251 · cited 1×
“Dephosphorylation of c-Myc by ABPR56C leads to its ubiquitination and subsequent degradation; a mutant form of c-Myc that is resistant to PP2A activity transforms cells in a similar manner to small t transformation (Arnold and Sears, 2006).”
BackgroundRegulation of Synaptic Strength by Protein Phosphatase 1
Morishita, W., Connor, J. H., Xia, H., Quinlan, E. M., Shenolikar, S., & Malenka, R. C. (2001) · Neuron · doi:10.1016/s0896-6273(01)00554-2 · Cited by 227
Adams, D. G., Coffee, R. L., Zhang, H., Pelech, S., Strack, S., & Wadzinski, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502464200 · Cited by 133
Protein phosphatase 2A interacts with and directly dephosphorylates RelA
Yang, J., Fan, G.-H., Wadzinski, B. E., Sakurai, H., & Richmond, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106103200 · Cited by 130 · cited 1×
“Like the Ras-Raf1-MEK-ERK pathway, PP2A has been shown to play a crucial regulatory role at many steps in the IKK–NF- B signal transduction pathway (Sun et al., 1995; DiDonato et al., 1997; Yang et al., 2001; Fu et al., 2003; Li et al., 2006).”
BackgroundSelf-citationFu, D.-X., Kuo, Y.-L., Liu, B.-Y., Jeang, K.-T., & Giam, C.-Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210631200 · Cited by 95
Cited by
The extended PP1 toolkit: designed to create specificity
Bollen, M., Peti, W., Ragusa, M. J., & Beullens, M. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.002 · Cited by 508
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
Haemmerle, M., Taylor, M. L., Gutschner, T., Pradeep, S., Cho, M. S., Sheng, J., Lyons, Y. M., Nagaraja, A. S., Dood, R. L., Wen, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00411-z · Cited by 274
Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates
Brautigan, D. L., & Shenolikar, S. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012332 · Cited by 191
Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases
Lambrecht, C., Haesen, D., Sents, W., Ivanova, E., & Janssens, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-562-0_17 · Cited by 140
Virulence-Associated Enzymes of Cryptococcus neoformans
Almeida, F., Wolf, J. M., & Casadevall, A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00103-15 · Cited by 141
Metadata
- Authors
- McConnell, J. L., & Wadzinski, B. E.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 75
- Issue
- 6
- Pages
- 1249-1261
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2165408960
- Cited by
- 174
- References
- 16
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.